default author photo

Guido Ferrari

Duke University - Division of Surgical Sciences

100 Fuqua Drive

Durham, NC 27715

United States

SCHOLARLY PAPERS

2

DOWNLOADS

104

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Co-Administration of HIV Env Protein with DNA and/or NYVAC Vaccines in Humans Results in Earlier and Potent Generation of Anti-Env Antibody Responses

Number of pages: 184 Posted: 30 Jan 2019
University of Lausanne - Service of Immunology and Allergy, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Duke University - Medical Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Division of Surgical Sciences, Duke University - Division of Surgical Sciences, EuroVacc Foundation, Global Solutions for Infectious Diseases, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Consejo Superior de Investigaciones Científicas, University of Regensburg, University of Lausanne - Service of Immunology and Allergy, University of Lausanne - Service of Immunology and Allergy, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Independent
Downloads 71 (867,774)

Abstract:

Loading...

HIV, Vaccine, prime-boost, co-administration, Env protein, antibody response

2.

Anti-V2 Antibodies Virus Vulnerability Revealed by Envelope V1 Deletion in HIV Vaccine Candidates

Number of pages: 87 Posted: 21 Oct 2020
National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health (NIH) - Section on Intercellular Interactions, Advanced Bioscience Laboratories, Advanced Bioscience Laboratories, New York University (NYU) - NYU Langone Health, New York University (NYU) - NYU Langone Health, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Duke University - Division of Surgical Sciences, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Structural Biology Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, Duke University - Department of Surgery, Duke University - Division of Surgical Sciences, Duke University - Medical Center, Duke University - Duke Human Vaccine Institute, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute - Biostatistics and Data Management Section, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research - AIDS and Cancer Virus Program, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Section on Intercellular Interactions, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, New York University (NYU) - NYU Langone Health and Medical University of Bialystok - Centre for Bioinformatics and Data Analysis
Downloads 33 (1,277,121)

Abstract:

Loading...

HIV, SIV, V1/V2, V1, ALVAC